Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

Clinical trial NCT00201838 · COMPLETED

Trial details

NCT number: NCT00201838
Sponsor: Ohio State University Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms Adenocarcinoma

Start date: 2001-07-01
Primary completion: 2006-10-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.